Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (11) , 1759-1765
- https://doi.org/10.1016/0006-2952(90)90122-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenografTBiochemical Pharmacology, 1989
- Deletion and hypermethylation of thymidine kinase gene in V79 Chinese hamster cells resistant to bromodeoxyuridineSomatic Cell and Molecular Genetics, 1988
- Determination of thymidylate synthase activity in colon tumor tissues after treatment with 5-fluorouracilBiochemical Pharmacology, 1987
- Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomasBiochemical Pharmacology, 1986
- Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycleAnalytical Biochemistry, 1984
- Methods for the complete analysis of 5-fluorouracil metabolites in cell extractsAnalytical Biochemistry, 1981
- On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived miceCancer, 1980
- A radioimmunoassay for measurement of serum thymidineAnalytical Biochemistry, 1973
- A Genetically Distinct Thymidine Kinase in Mammalian MitochondriaJournal of Biological Chemistry, 1973
- Mitochondrial thymidine kinase of bromodeoxyuridine-resistant, kinase-deficient HeLa(BU25) cellsBiochemical and Biophysical Research Communications, 1972